The Safety Profiles of Avacopan on Microscopic Polyangiitis and Granulomatosis with Polyangiitis: A Real-World Pharmacovigilance Analysis
October 2025
in “
Frontiers in Immunology
”
Studysummary In this study, researchers analyzed adverse events linked to avacopan using FDA data, finding no high-priority safety concerns but identifying five potential new adverse events, including alopecia, primarily among American patients, and noting a higher risk of liver dysfunction in Japanese patients.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on frontiersin.org →